Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: Phase III randomized, mechanical prophylaxis-controlled, open-label study
Authors:
- Masato SakonMSMasato Sakon
- Mashio NakamuraMNMashio Nakamura
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 130 (3) , e52-e59
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label studyThrombosis Research, 2010
- Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database studyJournal of Thrombosis and Thrombolysis, 2009
- Incidence of venous thromboembolism following major abdominal surgery: a multi‐center, prospective epidemiological study in JapanJournal of Thrombosis and Haemostasis, 2006
- Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for CancerNew England Journal of Medicine, 2002
- Surgery for germ cell tumorsSeminars in Surgical Oncology, 2000
- Deep Venous Thrombosis After Total Hip or Total Knee Arthroplasty in Patients in JapanClinical Orthopaedics and Related Research, 2000
- Lifestyle, fibrinolysis and lipids.International Journal of Clinical Pharmacy, 1997
- Results of extensive surgery for pancreatic carcinomaCancer, 1996
- Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolismBlood Coagulation & Fibrinolysis, 1995
- Prolonged survival of stomach cancer patients after extensive surgery and adjuvant treatment: An overview of the japanese experienceSeminars in Surgical Oncology, 1991